ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 22 filers reported holding ARMATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,747 | +674600.0% | 2,249 | +224800.0% | 0.00% | – |
| Q2 2023 | $1 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2023 | $6,684 | -22.1% | 4,002 | -42.2% | 0.00% | – |
| Q4 2022 | $8,578 | +7.2% | 6,918 | +269.0% | 0.00% | – |
| Q3 2022 | $8,000 | -33.3% | 1,875 | -40.1% | 0.00% | – |
| Q2 2022 | $12,000 | -7.7% | 3,131 | +14.2% | 0.00% | – |
| Q1 2022 | $13,000 | +18.2% | 2,741 | +34.6% | 0.00% | – |
| Q4 2021 | $11,000 | 0.0% | 2,036 | -29.8% | 0.00% | – |
| Q3 2021 | $11,000 | +83.3% | 2,902 | +98.0% | 0.00% | – |
| Q2 2021 | $6,000 | -79.3% | 1,466 | -75.6% | 0.00% | – |
| Q1 2021 | $29,000 | +190.0% | 6,017 | +73.4% | 0.00% | – |
| Q4 2020 | $10,000 | – | 3,471 | +347000.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 1,672 | -26.6% | 0.00% | – |
| Q1 2020 | $7,000 | +133.3% | 2,278 | +192.1% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 780 | +36.4% | 0.00% | – |
| Q3 2019 | $2,000 | -83.3% | 572 | -80.2% | 0.00% | – |
| Q2 2019 | $12,000 | – | 2,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SeaCrest Wealth Management, LLC | 13,500 | $65,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 48,400 | $231,000 | 0.00% |
| LOOMIS SAYLES & CO L P | 129,956 | $621,000 | 0.00% |
| Renaissance Technologies | 123,816 | $592,000 | 0.00% |
| ROYAL BANK OF CANADA | 50 | $0 | 0.00% |
| VANGUARD GROUP INC | 75,596 | $362,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 100 | $0 | 0.00% |
| UBS Group AG | 6,017 | $29,000 | 0.00% |
| Sowell Financial Services LLC | 109 | $0 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $3,000 | 0.00% |